Anti-amyloid Therapy of Alzheimer's Disease: Current State and Prospects.
Biochemistry (Mosc)
; 83(9): 1057-1067, 2018 Sep.
Article
en En
| MEDLINE
| ID: mdl-30472944
Drug development for the treatment of Alzheimer's disease (AD) has been for a long time focused on agents that were expected to support endogenous ß-amyloid (Aß) in a monomeric state and destroy soluble Aß oligomers and insoluble Aß aggregates. However, this strategy has failed over the last 20 years and was eventually abandoned. In this review, we propose a new approach to the anti-amyloid AD therapy based on the latest achievements in understanding molecular causes of cerebral amyloidosis in AD animal models.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Péptidos beta-Amiloides
/
Enfermedad de Alzheimer
/
Anticuerpos Monoclonales
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Biochemistry (Mosc)
Año:
2018
Tipo del documento:
Article
País de afiliación:
Rusia
Pais de publicación:
Estados Unidos